Charles A Rowland Jr Viking Therapeutics, Inc. (VKTX) insider trading activity

Charles A Rowland Jr is of Viking Therapeutics, Inc.. Currently has a direct ownership of 33,150 shares of VKTX, which is worth approximately $1.32 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 3,150 shares (Common stock, par value $0.00001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.2K

10.5% 3M change

10.5% 12M change

Total Value Held $1.32 Million

Charles A Rowland Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	-	3,150 Added 8.68%	33,150 Common stock, par valu...
Oct 27 2025	SELL Open market or private sale	$2,134,200 $35.57 p/Share	60,000 Reduced 66.67%	30,000 Common stock, par valu...
Oct 27 2025	BUY Grant, award, or other acquisition	$303,000 $5.05 p/Share	60,000 Added 40.0%	90,000 Common stock, par valu...
May 16 2023	SELL Open market or private sale	$1,000,000 $25.0 p/Share	40,000 Reduced 57.14%	30,000 Common stock, par valu...
May 16 2023	BUY Exercise of conversion of derivative security	$43,200 $1.08 p/Share	40,000 Added 36.36%	70,000 Common stock, par valu...

Also insider at

BPMC

Blueprint Medicines Corp Healthcare

Director

GBIO

Generation Bio Co. Healthcare

ORTX

Orchard Therapeutics plc Healthcare

NBRV

Nabriva Therapeutics plc Healthcare

Director

CAR